Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-11-15Clinical Trial Update: Web-Based Collaborative Care for Patients With Diabetes and Depression [NA]
Clinical trial update describing a web-based collaborative care program for patients with type 2 diabetes mellitus and depression. The entry…
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) [Phase 4]
A Phase 4 clinical trial update reports completed evaluation of testosterone therapy in men with type 2 diabetes mellitus and hypogonadism.
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Partners in Care Diabetes Self-management Intervention [NA]
This clinical trial update notes that the Partners in Care Diabetes Self-management Intervention study with Type 2 diabetes mellitus has com…
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: UCSD Take Charge Study [NA]
This entry notes that the UCSD Take Charge Study, a clinical trial related to overweight and obesity (including Type 2 diabetes consideratio…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients
Observation study completion update for GLucobay (miglitol) evaluating efficacy and safety in patients with type 2 diabetes mellitus.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-11-12FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories to market Pioglitazone and Glimepiride as a fixed-dose combination.
-
FDA approval · 2013-11-12FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc., updating or expanding th…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure. [Phase 4]
A Phase 4 trial evaluating the safety and efficacy of two insulin regimens in Type 2 diabetes patients with moderate renal impairment: insul…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes [Phase 4]
A completed Phase 4 trial comparing telmisartan and ramipril for effects on renal endothelial dysfunction in patients with type 2 diabetes a…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial update investigates short-term alpha-lipoic acid to prevent contrast-induced acute kidney injury and endothelial dy…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects [Phase 1]
This Phase 1 trial in healthy subjects evaluated the bioequivalence between two insulin degludec/liraglutide formulations (B5 and V2).
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: SMOOTH - Blood Pressure Control in Diabetic/Obese Patients [Phase 4]
Phase 4 clinical trial SMOOTH evaluated blood pressure control in adults with hypertension and type 2 diabetes, including obese participants…
-
FDA approval · 2013-11-07FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company. This action updates the product's labe…
-
CLINICAL_TRIALS research · 2013-11-07Clinical Trial Update: Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes [NA]
A clinical trial update from Tel Aviv University examining how meal timing influences postprandial glucose, insulin, and GLP-1 levels in ind…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes [Phase 1]
A Phase I study evaluating 8 weeks of continuous treatment with polyethylene glycol loxenatide in patients with Type 2 diabetes has complete…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Pharmacist Intervention for Glycemic Control in The Community [NA]
The clinical trial update notes completion of a study evaluating a pharmacist-led intervention to improve glycemic control in the community.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Evaluation of Dapagliflozin Taken Twice-daily [Phase 3]
A Phase 3 trial evaluated twice-daily dapagliflozin for Type 2 diabetes; results were posted in November 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril [Phase 3]
Phase 3 DETAIL trial evaluating exposure to telmisartan and enalapril in patients with hypertension and type 2 diabetes has completed.
-
CLINICAL_TRIALS research · 2013-11-01Clinical Trial Update: Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines [NA]
This clinical trial update describes a study comparing bariatric/gastric surgery to intensive medical therapy for the prevention and treatme…
-
FDA approval · 2013-10-31FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers [Phase 1]
This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of ZYD1 following subcutaneous administration in healthy volunte…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Community Based Participatory Research With Immigrant Chinese With Diabetes [NA]
This ClinicalTrials.gov update reports a completed community-based participatory research study involving immigrant Chinese adults with Type…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 efficacy and safety study of MP-513 in combination with a thiazolidinedione in type 2 diabetes has completed with results posted i…
-
CLINICAL_TRIALS research · 2013-10-28Clinical Trial Update: Malignancy Meta Analysis for BRL49653
Clinical trial update presenting a meta-analysis of malignancy risk for BRL49653 in Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients [Phase 4]
Phase 4 trial evaluating triple blockade of the renin-angiotensin-aldosterone system in proteinuric diabetic patients (Type 1 and Type 2) ha…